The Latest Cardiac and Vascular News
Amersham, UK, Minnesota, USA, and Melbourne, Australia — 30 July 2020 — GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVertTM contrast minimization devices, […]
MINNEAPOLIS–(BUSINESS WIRE)–Minnesota-based Osprey Medical Inc. (ASX:OSP) (Osprey or Company) today announces that it has entered into an agreement with Allan Gray, a leading investment management firm, to subscribe for approximately 64.5m CHESS Depositary Interests (CDIs) in the Company (representing approximately 32.3m shares of common stock) through the Australian Securities Exchange (ASX) at […]
Highlights: • Osprey Medical showcased at the 30th Transcatheter Cardiovascular Therapeutics (TCT) conference with two scientific sessions and moderated abstract sessions focused on awareness and prevention of contrast induced Acute Kidney Injury (AKI) • Osprey Medical featured its Be Kind to Kidneys Program, patient education materials and GE partnership at […]
Osprey Medical (ASX:OSP) based in Minnetonka, MN continues to make strong progress toward their mission of making coronary angiography (heart x-ray imaging) safer for patients with poor kidney function. They are rapidly growing US sales with a direct sales force; in Q2 2017 sales were up 240% over the prior […]
